Search results
Andy Barr: Defending Taiwan is vital to U.S. national security and economic interests. | Opinion
Lexington Herald-Leader McClatchy via AOL· 1 day agoOpEd: My recent trip to Taiwan was purposely designed to demonstrate an unwavering commitment to...
This wealthy white enclave was once home to newly freed Black Americans
Mother Jones· 1 day ago40 Acres and a Lie tells the history of an often-misunderstood government program that gave formerly...
Lyra McKee: More MTV footage shown in murder trial
BBC News· 1 day agoMore MTV footage has been shown in the Lyra McKee murder trial. The 29-year-old was watching a riot in the Creggan estate in April 2019 when she was...
Opinion | The GOP's latest cheap shot is about more than Merrick Garland
MSNBC via Yahoo News· 19 hours agoThe House voted to hold Attorney General Merrick Garland in contempt of Congress. It's the latest...
Analysis | Mace, Timmons survive primary challenges
Washington Post· 2 days agoHere are our colleague Zoe Glasser’s top picks. Rep. William Timmons (R-S.C.) defeated a primary challenger last night who had pledged to join the House...
After his historic guilty verdict, Trump is focused on revenge
NBC NEWS· 4 days agoDonald Trump wants to talk about revenge, and neither Sean Hannity nor Dr. Phil can stop him. Fresh...
Attorney General Merrick Garland held in contempt of US Congress
BBC News· 2 days agoThe US House of Representatives voted on Wednesday to hold Attorney General Merrick Garland in...
21 Celebrities Who Are Battling Rare Chronic Illnesses
SheKnows via Yahoo News· 20 hours agoLiving with, treating and understanding the effects of a rare and/or chronic illness is a serious...
U.S. House GOP votes to hold attorney general in contempt in dispute over audio recording
South Carolina Daily Gazette via Yahoo News· 1 day agoWASHINGTON — U.S. House Republicans voted Wednesday to hold Attorney General Merrick Garland in...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 15 hours agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following insider selling activity. 392,597 shares changed hands during trading, ...